NCT04684290View on ClinicalTrials.gov

Surgical Septal Myectomy vs Percutaneous Transluminal Alcohol Septal Ablation in Patients With Hypertrophic Obstructive Cardiomyopathy

NARecruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

June 30, 2021

Primary Completion Date

May 1, 2025

Study Completion Date

May 1, 2026

Conditions
Hypertrophic Cardiomyopathy
Interventions
PROCEDURE

Alcohol Septal Ablation

Participants will be treated with alcohol septal ablation.

PROCEDURE

Surgical Septal Myectomy

Participants will be treated with surgical septal myectomy.

Trial Locations (1)

3435cm

RECRUITING

St. Antonius Hospital, Nieuwegein

Sponsors

Collaborators (1)

Erasmus Medical Center
All Listed Sponsors
collaborator

Erasmus Medical Center

OTHER

lead

St. Antonius Hospital

OTHER

NCT04684290 - Surgical Septal Myectomy vs Percutaneous Transluminal Alcohol Septal Ablation in Patients With Hypertrophic Obstructive Cardiomyopathy | Biotech Hunter | Biotech Hunter